BRG Borregaard

Borregaard ASA: Borregaard invests further into Alginor 

Borregaard ASA: Borregaard invests further into Alginor 



Borregaard has participated with its fully diluted pro-rata share (35%) in the NOK 400 million capital raise in the marine biotech company Alginor to fund the next step of the biorefinery expansion. The funds from Borregaard were pre-committed. In aggregate the committed investments into Alginor from Borregaard will now total approximately NOK 408 million. 

Alginor intends to carry out a repair offering directed towards existing shareholders and potential new shareholders. A subsequent offering towards Borregaard will be made to ensure that Borregaard retains its 35% fully diluted ownership in Alginor.  

For more information about Alginor and the capital raise, see . 

 

Contact: 

Director Investor Relations, Knut-Harald Bakke,

This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act



EN
19/06/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Borregaard

ABGSC Pulp & Paper Research ... (+3)
  • ABGSC Pulp & Paper Research
  • Ali Shemmari
  • Martin Melbye

Costs push prices higher

A long list of price increases as costs push prices higher. Q2e EBIT likely down q-o-q: higher maintenance costs. Smart to buy when macro is low.

ABGSC Pulp & Paper Research ... (+3)
  • ABGSC Pulp & Paper Research
  • Ali Shemmari
  • Martin Melbye

Q2 preview

Borregaard will report its next quarterly results on 17 July. We reiterate BUY with a TP of NOK 215 (205). Q2'24e EBITDA of ~NOK 500m.

Niclas Gehin
  • Niclas Gehin

Borregaard (Buy, TP: NOK210.00) - Set for continued earnings growth

We forecast Q2 EBITDA of NOK514m and EPS of NOK2.7 (results due at 07:00 CET on 17 July). We have raised our 2025–2026e EPS by 3% to reflect BioSolutions improvements and are now ~2% above Bloomberg consensus. With the stock trading at a 2025–2026e EV/EBITDA of 9.4x and 10.4x, we continue to see upside potential. We reiterate our BUY and have raised our target price to NOK210 (200).

 PRESS RELEASE

Borregaard ASA: Borregaard invests further into Alginor 

Borregaard ASA: Borregaard invests further into Alginor  Borregaard has participated with its fully diluted pro-rata share (35%) in the NOK 400 million capital raise in the marine biotech company Alginor to fund the next step of the biorefinery expansion. The funds from Borregaard were pre-committed. In aggregate the committed investments into Alginor from Borregaard will now total approximately NOK 408 million.  Alginor intends to carry out a repair offering directed towards existing shareholders and potential new shareholders. A subsequent offering towards Borregaard will be made to ensu...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch